LEVODOPA FORMULATIONS FOR RAPID RELIEF OF PARKINSON'S DISEASE Russian patent published in 2019 - IPC A61K31/198 A61K9/12 A61K9/14 A61P25/16 

Abstract RU 2685718 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to medicine and concerns a method of providing rapid relief of motor fluctuations in a Parkinson's disease patient, including administering at least one dose of levodopa by inhalation to a Parkinson's disease patient, wherein the dose is selected such that, within 10 minutes of administration of levodopa by inhalation, the patient's plasma levodopa concentration increases by at least 200 ng/ml as compared to the patient's plasma levodopa concentration prior to administration; and maintaining said concentration, which has increased by at least 200 ng/ml for a period of time of at least 15 minutes after administration. Group of inventions also relates to a method of providing rapid relief of motor fluctuations in a Parkinson's disease patient, comprising administering to the patient from 20 mg to 50 mg of FPD levodopa by inhalation.

EFFECT: group of inventions provides treatment of motor fluctuations resulting from an insufficient degree of controlled level of levodopa in the patient's blood plasma.

14 cl, 2 ex, 9 dwg, 8 tbl

Similar patents RU2685718C2

Title Year Author Number
REDUCTION OF INPATIENT VARIABILITY OF LEVODOPA CONCENTRATIONS IN BLOOD PLASMA 2013
  • Batiki Richard P.
  • Frid Martin
RU2682681C2
RAPID REDUCTION OF MOTOR FLUCTUATIONS ACCOMPANYING PARKINSON'S DISEASE 2014
  • Batiki Richard P.
  • Frid Martin
  • Lipp Majkl M.
RU2698330C2
COMPOSITIONS FOR CONTINUOUS CONTROL OF DOPA-DECARBOXYLASE INHIBITORS 2010
  • Jakobi-Tseevi Oron
  • Nemas Mara
RU2559083C9
COMPOSITIONS FOR CONTINUOUS ADMINISTRATION OF DOPA-DECARBOXYLASE INHIBITORS 2010
  • Yakobi-Tseevi Oron
  • Nemas Mara
RU2678839C2
METHOD FOR TREATMENT OF PARKINSON'S DISEASE 2014
  • Yakobi-Tseevi Oron
RU2677278C2
INTRODUCTION MODE FOR NITROCATECHOLS 2011
  • Soares Da Silva Patricio Manuel Vieira Araujo
  • Nunes Teresal Lucia Silva Pereira
  • Wright Lyndon Christopher
  • Palma Pedro Nuno Leal
  • Learmonth David Alexander
RU2639131C2
ULTRA LOW DENSITY INHALATION POWDERS 2013
  • Lipp Majkl M.
  • Batiki Richard P.
RU2670987C2
PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF LEVODOPA PRODRUG AND METHODS OF USING 2010
  • Mao Chen
  • Pargaonkar Nikkhil
  • Morer Laura E.
  • Ma Sarina Grehjs Kharris
RU2537137C2
CONTINUOUS ADMINISTRATION OF L-DOPA, DOPA DECARBOXYLASE INHIBITORS, CATECHOL-METHYLTRANSFERASE INHIBITORS AND INTENDED FOR THIS COMPOSITION 2011
  • Yakobi-Tseevi Oron
  • Nemas Mara
RU2740080C2
PHARMACEUTICAL COMPOSITION IN FORM OF SINGLE ORAL DOSE CONTAINING LEVODOPA, CARBIDOPA AND ENTACAPONE, OR SALTS THEREOF 2009
  • Gupta Jatendra Kumar
  • Dzhain Girish Kumar
  • Talvar Munish
  • Mashalkar Manodzh
RU2519159C2

RU 2 685 718 C2

Authors

Frid Martin

Batiki Richard

Lipp Majkl M.

Dates

2019-04-23Published

2013-10-21Filed